Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diabetes type 2: magnitudes of agonist-evoked platelet activity markers in vitro demonstrate a substantial individual dependence.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·2026
Same author

Venetoclax combinations in untreated CLL: 5-year results and patient-reported outcomes analysis of the CLL13/GAIA trial.

Blood·2026
Same author

Altered platelet function in persistent depressive disorder: a study of density subpopulations and fibrinogen binding.

Journal of neural transmission (Vienna, Austria : 1996)·2026
Same author

Patients' experiences of receiving hospital care from a mobile care unit - a qualitative interview study.

International journal of qualitative studies on health and well-being·2026
Same author

Clinical Characteristics in Swedish Children With and Without Autoantibodies at the Time of Type 1 Diabetes Diagnosis.

Diabetes care·2025
Same author

Platelet-activating histone/antihistone IgG complexes in anti-PF4-negative thrombosis and thrombocytopenia syndrome.

Blood advances·2025

Related Experiment Video

Updated: Jun 12, 2026

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
10:08

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

Platelet density distribution in essential thrombocythemia.

Micha Milovanovic1, Kourosh Lotfi, Tomas Lindahl

  • 1Department of Internal Medicine, Vrinnevi Hospital, Norrköping, Sweden. micmi @ isv.liu.se

Pathophysiology of Haemostasis and Thrombosis
|May 21, 2010
PubMed
Summary

Essential thrombocythemia (ET) platelets show normal density distribution, explaining the low risk of severe bleeding despite high platelet counts. This suggests a mix of normal and abnormal platelet production in ET.

More Related Videos

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
04:32

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

Related Experiment Videos

Last Updated: Jun 12, 2026

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets
10:08

Flow Cytometry Analysis of Tissue Factor Expression in Human Platelets

Published on: November 22, 2024

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
04:32

A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry

Published on: June 5, 2019

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

Area of Science:

  • Hematology
  • Platelet Biology
  • Thrombocythemia Research

Background:

  • Essential thrombocythemia (ET) is marked by elevated platelet counts and a paradoxically low risk of severe hemorrhage.
  • Platelet density variations correlate with organelle content, influencing platelet function and granule release.

Purpose of the Study:

  • To investigate platelet density subpopulations in ET patients compared to healthy controls.
  • To explore the relationship between platelet density, in vivo activity (platelet-bound fibrinogen), and activation markers (CD40L, P-selectin).

Main Methods:

  • Platelets from ET patients and healthy volunteers were separated into density subpopulations using a linear Percoll™ gradient.
  • Platelet-bound fibrinogen, CD40 ligand (CD40L), and P-selectin levels were quantified in each density fraction via flow cytometry.

Main Results:

  • Both ET patients and controls exhibited a similar single-peak platelet density distribution.
  • Higher density platelets showed increased surface-bound fibrinogen and signs of platelet release (lower CD40L/P-selectin).
  • Lower density (lighter) platelets had more surface-bound fibrinogen and elevated CD40L, suggesting distinct functional profiles.

Conclusions:

  • The normal density distribution of platelets in ET provides a potential explanation for the infrequent occurrence of severe bleeding.
  • ET may involve the co-production of platelets from both normal megakaryocytes and malignant clones, spanning a range of densities and functions.